Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 32

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00476242Phase 2/3Completed
Memantine as a Supplement to Naltrexone in Treating Heroin Dependence
Heroin DependenceOpioid Dependence
Principalinvestigator
NCT01024335Phase 2/3Completed
Dronabinol Naltrexone Treatment for Opioid Dependence
Opioid Dependence
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Columbia University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Leslie Amass, Ph.D.

University of Colorado, Denver

Moderately Similar
6 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Walter Ling, M.D.

Friends Research Institute, Inc.

Moderately Similar
28 trials

Shared therapeutic areas:

Opioid-Related DisordersHeroin Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Jazmin Camchong, PhD

University of Minnesota

Moderately Similar
6 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Mark Greenwald, PhD

Wayne State University

Moderately Similar
15 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Kenneth Silverman, Ph.D.

Johns Hopkins University

Moderately Similar
8 trials

Shared therapeutic areas:

Opioid-Related DisordersHeroin Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Herbert Kleber, M.D.

New York State Psychiatric Institute

Moderately Similar
9 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)New York State Psychiatric Institute
Similarity Score30%

Charles O'Brien, M.D., Ph.D.

PDVAMC Treatment Research Center

Related
7 trials

Shared therapeutic areas:

Opioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Elizabeth Ralevski, Ph.D.

Yale University

Related
6 trials

Shared therapeutic areas:

Opioid-Related Disorders
Similarity Score15%

Robert P Schwartz, M.D.

Friends Research Institute, Inc.

Related
6 trials

Shared therapeutic areas:

Opioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Jeffrey L Schnipper, MD, MPH

Brigham and Women's Hospital

Related
8 trials

Shared therapeutic areas:

Opioid-Related Disorders
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00476242Phase 2/3PrincipalInvestigator

Memantine as a Supplement to Naltrexone in Treating Heroin Dependence

Heroin DependenceOpioid Dependence
Completed
NCT01024335Phase 2/3PrincipalInvestigator

Dronabinol Naltrexone Treatment for Opioid Dependence

Opioid Dependence
Completed

All 2 trials loaded